Before the uncertainty caused by the variants of the new coronavirus, the pharmaceutical company Pfizer assures that a new vaccine against the omicron variant will be ready in March.
Dr. Mauricio González, an internist at the Metropolitan Hospital in New York, comments on why this scientific research is necessary.